285 related articles for article (PubMed ID: 21111017)
1. Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants.
Gorzalka BB; Hill MN
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1575-85. PubMed ID: 21111017
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants.
Hill MN; Hillard CJ; Bambico FR; Patel S; Gorzalka BB; Gobbi G
Trends Pharmacol Sci; 2009 Sep; 30(9):484-93. PubMed ID: 19732971
[TBL] [Abstract][Full Text] [Related]
3. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.
Duman CH; Schlesinger L; Kodama M; Russell DS; Duman RS
Biol Psychiatry; 2007 Mar; 61(5):661-70. PubMed ID: 16945347
[TBL] [Abstract][Full Text] [Related]
4. Roles of glutamate signaling in preclinical and/or mechanistic models of depression.
Tokita K; Yamaji T; Hashimoto K
Pharmacol Biochem Behav; 2012 Feb; 100(4):688-704. PubMed ID: 21536063
[TBL] [Abstract][Full Text] [Related]
5. Antistress properties of antidepressant drugs and their clinical implications.
Calabrese F; Molteni R; Riva MA
Pharmacol Ther; 2011 Oct; 132(1):39-56. PubMed ID: 21640755
[TBL] [Abstract][Full Text] [Related]
6. Circadian rhythms and treatment implications in depression.
Monteleone P; Martiadis V; Maj M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1569-74. PubMed ID: 20691746
[TBL] [Abstract][Full Text] [Related]
7. Cytokines as mediators of depression: what can we learn from animal studies?
Dunn AJ; Swiergiel AH; de Beaurepaire R
Neurosci Biobehav Rev; 2005; 29(4-5):891-909. PubMed ID: 15885777
[TBL] [Abstract][Full Text] [Related]
8. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders.
Gorzalka BB; Hill MN; Hillard CJ
Neurosci Biobehav Rev; 2008 Aug; 32(6):1152-60. PubMed ID: 18433869
[TBL] [Abstract][Full Text] [Related]
9. The WAG/Rij strain: a genetic animal model of absence epilepsy with comorbidity of depression [corrected].
Sarkisova K; van Luijtelaar G
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):854-76. PubMed ID: 21093520
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoids and stress.
Riebe CJ; Wotjak CT
Stress; 2011 Jul; 14(4):384-97. PubMed ID: 21663537
[TBL] [Abstract][Full Text] [Related]
11. The keys to improving depression outcomes.
Rizvi SJ; Kennedy SH
Eur Neuropsychopharmacol; 2011 Sep; 21 Suppl 4():S694-702. PubMed ID: 21924209
[TBL] [Abstract][Full Text] [Related]
12. Impairments in endocannabinoid signaling and depressive illness.
Hill MN; Gorzalka BB
JAMA; 2009 Mar; 301(11):1165-6. PubMed ID: 19293417
[No Abstract] [Full Text] [Related]
13. [Neuroplasticity and depression].
Czéh B; Simon M
Psychiatr Hung; 2005; 20(1):4-17. PubMed ID: 16389729
[TBL] [Abstract][Full Text] [Related]
14. [Neurobiological mechanisms of depression and antidepressant therapy].
Shishkina GT; Dygalo NN
Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(2):138-52. PubMed ID: 20469588
[TBL] [Abstract][Full Text] [Related]
15. Role of the endocannabinoid system in depression and suicide.
Vinod KY; Hungund BL
Trends Pharmacol Sci; 2006 Oct; 27(10):539-45. PubMed ID: 16919786
[TBL] [Abstract][Full Text] [Related]
16. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants.
Pałucha A; Pilc A
Pol J Pharmacol; 2002; 54(6):581-6. PubMed ID: 12866712
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid-mediated modulation of stress responses: physiological and pathophysiological significance.
Finn DP
Immunobiology; 2010 Aug; 215(8):629-46. PubMed ID: 19616342
[TBL] [Abstract][Full Text] [Related]
18. Symptom relief and facilitation of emotional processing.
Goodwin GM
Eur Neuropsychopharmacol; 2011 Sep; 21 Suppl 4():S710-5. PubMed ID: 21865015
[TBL] [Abstract][Full Text] [Related]
19. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
Ströhle A
Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of action of antidepressants and therapeutic perspectives].
Bourin M; David DJ; Jolliet P; Gardier A
Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
